TRIESELMANN, Thomas,GODBOUT, Cédrickx,HOENKE, Christoph,VINTONYAK, Viktor
申请号：
SG11202006302T
公开号：
SG11202006302TA
申请日:
2019.01.28
申请国别(地区):
SG
年份:
2020
代理人:
摘要：
The present invention relates to compounds of general formula I, wherein the groups R1 and R2 are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.
